O4‐11‐05: Long‐term oral lithium treatment attenuates motor disturbance in tauopathy model mice: Implications of autophagy promotion

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurobiology of Disease

• Publication date

  2012-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jalz.2012.05.1699PMID 22249108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

  2014cited by this paper
• Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.

  2011cited by this paper
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

  2010cited by this paper
• Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease

  2010cited by this paper
• Lithium induces clearance of protease resistant prion protein in prion‐infected cells by induction of autophagy

  2009cited by this paper
• Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.

  2009cited by this paper
• Lithium delays progression of amyotrophic lateral sclerosis

  2008cited by this paper
• Autophagic‐lysosomal perturbation enhances tau aggregation in transfectants with induced wild‐type tau expression

  2008cited by this paper
• Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.

  2007cited by this paper
• Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.

  2007cited by this paper
• Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

  2007cited by this paper
• Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert

  2006cited by this paper
• Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies

  2005cited by this paper
• Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.

  2005cited by this paper
• Lithium induces autophagy by inhibiting inositol monophosphatase

  2005cited by this paper
• Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.

  2004cited by this paper
• Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.

  2004cited by this paper
• Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

  2004cited by this paper
• Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium

  2004cited by this paper
• The effect of prolonged lithium administration on activity, reactivity, and endurance in the rat

  2004cited by this paper
• Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model

  2003cited by this paper
• Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.

  2002cited by this paper
• Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility

  2002cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

  2001cited by this paper
• Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments

  2001cited by this paper
• Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.

  2001cited by this paper
• Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice.

  2001cited by this paper
• Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice

  2001cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.

  1999cited by this paper
• Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate

  1998cited by this paper
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

  1997cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II

  1996cited by this paper
• Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules

  1996cited by this paper
• Alzheimer's disease: a cell biological perspective.

  1992cited by this paper
• A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1991cited by this paper

• Lithium mitigates hippocampal tau pathology in a rodent model of traumatic brain injury

  2025cites this paper
• Epilepsy and autophagy modulators: a therapeutic split

  2025cites this paper
• Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

  2024cites this paper
• Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives.

  2024cites this paper
• Effect of Lithium and Chloroquine on Neuronal Ultrastructure in a Melanoma Mice Model

  2024cites this paper
• Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator

  2023cites this paper
• Lithium engages autophagy for neuroprotection and neuroplasticity: translational evidence for therapy.

  2023cites this paper
• An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease.

  2023cites this paper
• Arsenic and Tau Phosphorylation: a Mechanistic Review

  2023cites this paper
• Oral administration of Lithium Chloride Ameliorate Spinal Cord Injury-Induced Hyperalgesia in Male Rats

  2022cites this paper
• Lithium Enhances Hippocampal Glucose Metabolism in an In Vitro Mice Model of Alzheimer’s Disease

  2022cites this paper
• Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma

  2022influential citation
• Lithium therapy subdues neuroinflammation to maintain pyramidal cells arborization and rescues neurobehavioural impairments in ovariectomized rats

  2022cites this paper
• Autophagy in health and disease: From molecular mechanisms to therapeutic target

  2022cites this paper
• Neuroprotektive Therapien bei Tauopathien

  2021cites this paper
• The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease

  2021cites this paper
• Autophagy and Tau Protein

  2021cites this paper
• Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders

  2021cites this paper
• Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles

  2021cites this paper
• Trehalose against Alzheimer's Disease: Insights into a Potential Therapy

  2020cites this paper
• Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy

  2020cites this paper
• Autophagic Dysfunction in Neurodegeneration

  2020cites this paper
• Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies

  2020cites this paper
• HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis.

  2020cites this paper
• Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.

  2020cites this paper
• Disease-modifying strategies in primary tauopathies.

  2019cites this paper
• Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity

  2019cites this paper
• Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases

  2019cites this paper
• Four-repeat tauopathies.

  2019cites this paper
• Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer’s Disease

  2019cites this paper
• Autophagy induction as a therapeutic strategy for neurodegenerative diseases.

  2019cites this paper
• Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

  2018cites this paper
• Lysosomes and Brain Health.

  2018cites this paper
• Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy

  2018cites this paper
• Selective autophagy as a potential therapeutic target for neurodegenerative disorders.

  2018cites this paper
• Lithium as a disease-modifying agent for prion diseases

  2018cites this paper
• Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models

  2018cites this paper
• mTORC1 Prevents Epithelial Damage During Inflammation and Inhibits Colitis-Associated Colorectal Cancer Development

  2018cites this paper
• Lithium promotes recovery of neurological function after spinal cord injury by inducing autophagy

  2018cites this paper
• Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases

  2018cites this paper
• New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease.

  2018cites this paper
• SLM, a novel carbazole‐based fluorophore attenuates okadaic acid‐induced tau hyperphosphorylation via down‐regulating GSK‐3&bgr; activity in SH‐SY5Y cells

  2017cites this paper
• Autophagy: an emerging key regulator of epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) cells

  2017cites this paper
• Autophagic flux control in neurodegeneration: Progress and precision targeting—Where do we stand?

  2017cites this paper
• Role of Autophagy Activation in Alleviating Alcohol Neurotoxicity

  2017cites this paper
• Lithium Chloride Facilitates Autophagy Following Spinal Cord Injury via ERK-dependent Pathway

  2017cites this paper
• Therapeutic implication of autophagy in neurodegenerative diseases

  2017cites this paper
• Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.

  2016cites this paper
• Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

  2016cites this paper
• Autophagy at the Cell, Tissue and Organismal Level

  2016cites this paper
• Stimulation of Tau Degradation

  2016cites this paper
• Physiological Role of Autophagy and Implications in Disease

  2016cites this paper
• Investigating the mechanisms underlying Alzheimer's disease using a novel organotypic brain slice culture model

  2016cites this paper
• The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy

  2016cites this paper
• Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

  2016cites this paper
• Compromised autophagy and neurodegenerative diseases

  2015cites this paper
• Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis

  2015influential citation
• Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis

  2015cites this paper
• Neurodegenerative changes in patients with clinical history of bipolar disorders

  2015cites this paper
• Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?

  2015cites this paper
• Lithium Ameliorates Motor Disturbance by Enhancing Autophagy in Tauopathy Model Mice

  2015cites this paper
• Lithium enhances survival and regrowth of spinal motoneurons after ventral root avulsion

  2014cites this paper
• Preconditioning Stimuli Induce Autophagy via Sphingosine Kinase 2 in Mouse Cortical Neurons*

  2014cites this paper
• Autophagy and ethanol neurotoxicity

  2014cites this paper
• Plastic Changes in the Spinal Cord in Motor Neuron Disease

  2014cites this paper
• Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases

  2014cites this paper
• Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

  2014cites this paper
• Lithium and autophagy.

  2014cites this paper
• Cell to cell spreading of misfolded proteins as a therapeutic target in motor neuron disease.

  2014cites this paper
• Lithium : de nouvelles perspectives thérapeutiques ?

  2014cites this paper
• Juntendo Medical Journal

  2014cites this paper
• Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.

  2013cites this paper
• Application and interpretation of current autophagy inhibitors and activators

  2013cites this paper
• Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.

  2013cites this paper
• The Importance of Tau Phosphorylation for Neurodegenerative Diseases

  2013cites this paper
• Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders

  2013cites this paper
• The regulation of phosphorylation of tau protein in Alzheimer's disease

  2013influential citation
• Therapeutic strategies for tau mediated neurodegeneration

  2012cites this paper
• Early Career Research Award

  2012cites this paper
• High throughput screening for drug discovery of autophagy modulators.

  2012cites this paper
• Autophagy and neurodegeneration.

  2012cites this paper
• Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases

  2012cites this paper